Proto-Script Pharmaceuticals Corp. agreed to acquire 49.29% in Wolverine Holding Corp. (OTCPK:WLVH) from Coral Capital Partners, Inc. for $0.06 million on December 22, 2014. Proto-Script Pharmaceuticals acquired 140 million shares and also acquired 200 million shares through a subscription agreement for $0.098 million. Blair Krueger of Krueger Group LLP acted as the escrow agent and legal advisor to Proto-Script Pharmaceuticals Corp.


Proto-Script Pharmaceuticals Corp. completed the acquisition of 49.29% in Wolverine Holding Corp. (OTCPK:WLVH) from Coral Capital Partners, Inc. on January 21, 2015.